Filter Results:
(414)
Show Results For
- All HBS Web
(705)
- Faculty Publications (414)
Show Results For
- All HBS Web
(705)
- Faculty Publications (414)
- July 2013 (Revised July 2015)
- Background Note
Innovating in Health Care—Framework
Contains the framework for the second-year Innovating in Health Care course. Delineates the role of six exogenous forces on new ventures: structure, financing, regulations, consumers, accountability, technology, and public policy and presents the essential elements of... View Details
Herzlinger, Regina E. "Innovating in Health Care—Framework." Harvard Business School Background Note 314-017, July 2013. (Revised July 2015.)
- June 2013
- Supplement
Philips-Visicu: eICU Video Supplement
Herzlinger, Regina. "Philips-Visicu: eICU Video Supplement." Harvard Business School Video Supplement 313-701, June 2013.
- April 2, 2013
- Article
Has the Glass Ceiling Been Shattered for Women Leading Major Companies?
With all the talk recently about the need for women to "lean in," the phrase that has gained instant currency with the publication of Sheryl Sandberg's book about how women should act more aggressively in pursuing their careers, it is worth asking: Has the glass... View Details
Keywords: Women And Leadership; Women; Glass Ceiling; Leadership; Personal Development and Career; Gender
Herzlinger, Regina E. "Has the Glass Ceiling Been Shattered for Women Leading Major Companies?" Huffington Post, The Blog (April 2, 2013).
- 2013
- White Paper
Benchmarks For Confronting The Challenges For Innovation In Health Care With A Modern Curriculum: 21st-Century Health Care Management Education: Confronting Challenges for Innovation with a Modern Curriculum
21st-Century Health Care Management Education:
Confronting Challenges for Innovation
with a Modern Curriculum View Details
Herzlinger, Regina E. "Benchmarks For Confronting The Challenges For Innovation In Health Care With A Modern Curriculum: 21st-Century Health Care Management Education: Confronting Challenges for Innovation with a Modern Curriculum." White Paper Series, Harvard Business School, Boston, MA, January 2013.
- December 2012 (Revised March 2013)
- Case
Agriculture in Mexico
By: David E. Bell, Regina Garcia-Cuellar and Cintra Scott
Bell, David E., Regina Garcia-Cuellar, and Cintra Scott. "Agriculture in Mexico." Harvard Business School Case 513-065, December 2012. (Revised March 2013.)
- September 2012 (Revised March 2014)
- Case
Reinventing Brainlab (A)
By: Regina E. Herzlinger, Vincent Dessain and Karol Misztal
The management of Germany's Brainlab AG, a leading provider of software-driven oncology and surgery solutions, needs to evaluate strategic options for proceeding without an exclusive hardware partner in its most profitable business segment. View Details
Keywords: Strategy; Information Infrastructure; Applications and Software; Medical Specialties; Health Care and Treatment; Information Technology Industry; Health Industry; Germany
Herzlinger, Regina E., Vincent Dessain, and Karol Misztal. "Reinventing Brainlab (A)." Harvard Business School Case 313-069, September 2012. (Revised March 2014.)
- September 2012 (Revised May 2015)
- Case
Philips-Visicu
By: Regina E. Herzlinger, Natalie Kindred and Sara M. McKinley
Would the advent of global payment models and ACOs create sufficient demand for a telemedicine offering covering the care continuum, from hospitals to the home? This was the decision facing Royal Philips Electronics (Philips), the Netherlands-based producer of... View Details
Keywords: Health Care; Philips; Visicu; Telemedicine; eICU; Accountable Care Organization; ACO; Bundled Payment; Hospital To Home; Patient Monitoring Devices; Home Health Care; Health Care and Treatment; Communication Technology; Quality; Safety; Performance Productivity; Performance Capacity; Performance Efficiency; Consumer Behavior; Emerging Markets; Health Industry; Telecommunications Industry; Netherlands
Herzlinger, Regina E., Natalie Kindred, and Sara M. McKinley. "Philips-Visicu." Harvard Business School Case 313-015, September 2012. (Revised May 2015.) (As companion reading for this case, see Regina E. Herzlinger and Charles Huang, "Note on Bundled Payment in Health Care," HBS No. 312-032 (Boston: Harvard Business Publishing, 2012).)
- September 2012 (Revised August 2014)
- Background Note
Note on Radiation Therapy, Stereotaxis, and Stereotactic Radiosurgery
By: Regina E. Herzlinger, Regina E. Herzlinger, T. Forcht Dagi and T. Forcht Dagi
Herzlinger, Regina E., and T. Forcht Dagi. "Note on Radiation Therapy, Stereotaxis, and Stereotactic Radiosurgery." Harvard Business School Background Note 313-073, September 2012. (Revised August 2014.)
- September 2012 (Revised August 2015)
- Case
Shanghai Pharmaceuticals
By: Regina E. Herzlinger and Natalie Kindred
Shanghai Pharmaceuticals (SPH), a vertically integrated Chinese pharmaceutical conglomerate, was considering its strategic options in the context of a rapidly evolving industry, policy, and economic environment. The company—essentially a collection of subsidiaries... View Details
Keywords: Business Subsidiaries; Business Conglomerates; Vertical Integration; Decision Choices and Conditions; Mergers and Acquisitions; Consolidation; Health Care and Treatment; Global Strategy; State Ownership; Pharmaceutical Industry; Health Industry; Shanghai; United States; Europe
Herzlinger, Regina E., and Natalie Kindred. "Shanghai Pharmaceuticals." Harvard Business School Case 313-016, September 2012. (Revised August 2015.)
- August 2012 (Revised August 2024)
- Module Note
Evaluating the Viability of Innovative Technology-Commercializing Ventures
Herzlinger, Regina E. "Evaluating the Viability of Innovative Technology-Commercializing Ventures." Harvard Business School Module Note 313-070, August 2012. (Revised August 2024.)
- August 2012 (Revised August 2024)
- Case
ABC Pharmaceuticals
By: Regina E. Herzlinger and Erik R. Sparks
This case asks students to price a new drug that is in Stage II of its clinical trials. It contains detailed estimates of the time required and costs for all the steps needed to commercialize a drug in the U.S. Students will learn virtually all the steps required to... View Details
Keywords: Drug Development; Price; Product; Product Launch; Health Industry; Technology Industry; Pharmaceutical Industry
Herzlinger, Regina E., and Erik R. Sparks. "ABC Pharmaceuticals." Harvard Business School Case 313-041, August 2012. (Revised August 2024.)
- August 2012 (Revised December 2023)
- Background Note
Note on Health Insurance Coverage, Coding, and Payment
By: Regina E. Herzlinger and Jo Ellen Slurzberg
This note explains how health care technology and service innovators receive payment from government insurers, in the U.S. and abroad, and from private insurers. It describes each of the three steps needed to obtain reimbursement: coverage, coding, and payment. It also... View Details
- August 2012 (Revised February 2021)
- Case
Hub and Spoke, HealthCare Global and Additional Focused Factory Models for Cancer Care
By: Regina E. Herzlinger, Amit Ghorawat, Meera Krishnan and Naiyya Saggi
This case compares and contrasts four different models for delivering cancer care in India and the US. Students are asked to select the best model in its alignment with the Six Forces in those two countries and Africa, to which one of the models is considering... View Details
Keywords: Cancer Care Services; Focused Factories For Cancer Care; Hub And Spoke Cancer Care; Cancer Care In The U.S.; Cancer Care In Africa; Cancer Care In India; Health Care and Treatment; Business Model; Six Sigma; Health Disorders; Health Industry; United States; India; Africa
Herzlinger, Regina E., Amit Ghorawat, Meera Krishnan, and Naiyya Saggi. "Hub and Spoke, HealthCare Global and Additional Focused Factory Models for Cancer Care." Harvard Business School Case 313-030, August 2012. (Revised February 2021.)
- August 2012 (Revised August 2012)
- Case
HealthAllies (A)
By: Regina E. Herzlinger and Michael Sherman
This case describes a "do good and do well" firm that enables individuals to buy health care services at discounted prices. It delineates the characteristics of the uninsured and others who are the primary targets for the firm. "HealthAllies (B)" provides information... View Details
Keywords: Entrepreneurship; Health Care and Treatment; Marketing Channels; Demand and Consumers; Commercialization; Health Industry
Herzlinger, Regina E., and Michael Sherman. "HealthAllies (A)." Harvard Business School Case 302-019, August 2012. (Revised from original August 2001 version.)
- August 2012 (Revised January 2013)
- Module Note
Note on Pharmaceutical Reimbursement in the U.S.
By: Regina Herzlinger and Drew Cronin-Fine
- August 2012 (Revised January 2013)
- Case
Public Health Insurance Exchanges: The Massachusetts Experience
By: Regina Herzlinger and Jordan Bazinsky
The CEO of Tufts Health Plan, James Roosevelt, is wondering whether to offer insurance products on the Massachusetts Connector, the first U.S. exchange. He wonders if he should enter these uncharted waters at all. And, if yes, with a broad network or a narrow network... View Details
- August 2012 (Revised August 2014)
- Case
Cancer Treatment Centers of America® (A)
By: Regina E. Herzlinger and Natalie Kindred
Cancer Treatment Centers of America (CTCA), a U.S. network of four privately owned oncology focused factory hospitals, was weighing options for growth. CTCA was entirely cancer focused and specialized in treating patients with complex and advanced-stage cancers, who... View Details
Keywords: Cancer; Cancer Treatment; Health Care; Healthcare; Accountability; Outcomes; Outcomes Measurement; Outcomes Reporting; Hub And Spoke Cancer Care; Hub And Spoke; Hub-and-spoke; Focused Factory; Mission and Purpose; Private Ownership; For-Profit Firms; Health Disorders; Medical Specialties; Policy; Business Model; Expansion; Decision Choices and Conditions; Advertising; Health Care and Treatment; Innovation and Invention; Health Industry; United States
Herzlinger, Regina E., and Natalie Kindred. "Cancer Treatment Centers of America® (A)." Harvard Business School Case 313-012, August 2012. (Revised August 2014.)
- Blog Post
Why Economic Conservatives Should Support the Individual Mandate in Health Care
Although many conservatives are gnashing their teeth about the Supreme Court's upholding the individual mandate, had it not been upheld, their worst nightmares would have occurred: government would have required hundreds of billions in additional taxes to pay for... View Details
Keywords: Health Care; Health Care Industry; Health Insurance; Health; Health Care and Treatment; Health Industry
Herzlinger, Regina E. "Why Economic Conservatives Should Support the Individual Mandate in Health Care." Huffington Post, The Blog (June 29, 2012). http://www.huffingtonpost.com/regina-e-herzlinger/health-insurance-market-mandate_b_1637762.html.
- May 2012 (Revised August 2014)
- Case
McKesson
By: Regina E. Herzlinger and Natalie Kindred
McKesson, a large, diversified drug distribution and health care IT company, is considering development of new business offerings to help private practice physicians remain independent. The company, with $122 billion in 2010 revenues, just made its first foray into... View Details
Keywords: Health Care Industry; Health Care Policy; Organizational Transformations; Health Services; Health Care and Treatment; Business Model; Service Operations; Change Management; Corporate Strategy; Information Technology; Policy; Pharmaceutical Industry; Health Industry; United States
Herzlinger, Regina E., and Natalie Kindred. "McKesson." Harvard Business School Case 312-002, May 2012. (Revised August 2014.)
- May 2012 (Revised April 2013)
- Teaching Plan
McKesson (TP)
By: Regina E. Herzlinger and Natalie Kindred
Herzlinger, Regina E., and Natalie Kindred. "McKesson (TP)." Harvard Business School Teaching Plan 312-121, May 2012. (Revised April 2013.)